News for CTI BioPharma Corp. (CTIC)

~ Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~

Pyxis Oncology adds biopharma veteran to board

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation...

MorphoSys shares have been climbing due to the approval chances of its lead candidate, pelabresib. Find out why I'm bullish on MOR stock.

/PRNewswire/ -- DelveInsight's Polycythemia Vera Market Insights report includes a comprehensive understanding of current treatment practices, polycythemia...

U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 25815 / Aug. 24, 2023 Securities and Exchange Commission v. Romero Cabral da Costa Neto, No. 1:...

Visiting attorney at the Washington, D.C. office of law firm used access to confidential client info to make illegal profits FOR IMMEDIATE RELEASE 2023-158 T...

/PRNewswire/ -- The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) ("Sobi" or the "Company") has, based on the authorisation of...

/PRNewswire/ -- The Sobi® EGM was convened today on 15 August 2023. At the EGM, the shareholders, in accordance with the proposed resolutions, resolved as...

GuruFocus Article or News written by GuruFocus Research and the topic is about:

/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) ("Sobi" or the "Company") calls for an Extraordinary General Meeting to be held on 15...

NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

MorphoSys is a German commercial-stage biopharmaceutical company. See why we initiate with a HOLD rating on MOR stock.

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

This article focuses on the influences towards a biotech company's share price, rather than their value. Read what to know about biotech catalysts here.